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URETHANE causes a very marked depression of mitotic activity of certain
mouse, rat and rabbit cells (Dustmin, 1947; Guyer and Claus, 1947). The present
work was undertaken to determine whether any such action would affect the
process ofmalignant transformation as brought about by painting a carcinogenic
hydrocarbon on mouse skin.
MATERIAL AND METHODS.
The carcinogen used was 1:2:5:6-dibenzanthracene and the urethane was
applied simultaneously. Young adult stock laboratory male mice were divided
into three groups and treated with solutions as shown in Table I.
TABLE I.-Number of Mice in Each Group and their Treatment.
Group. Number of
mice.
1 . 24 . 20per cent urethane (w/v) in asaturated
solution of l:2:5:6-dibenzanthracene
in acetone.
2 . 24 . Saturated solution of 1:2:5:6-dibenzan-
thracene in acetone.
3 . 18 . 20 per cent urethane in acetone (w/v).
A drop of the solution was applied interscapularly on the skin of the mice,
by paint-brush, once a week, for one year till the nmice died or were sacrificed.
In this way a local and simultaneous action of urethane and hydrocarbon on
mouse skin was obtained (Group 1). Group 2 served as a control, receiving the
hydrocarbon only. Group 3 was given urethane alone in order to observe any
independent effects which it might cause over a long period of time.
RESULTS.
Most of the mice in Groups 1 and 2 epilated at the site of application and
developed papillomas which eventually became malignant. The time taken for
these processes varied greatly between individual mice of both Groups 1 and 2,
but no group difference was noted. It was difficult to determine exactly when a
papilloma became malignant, but once the malignant process began, the
epitheliomas grew at a fairly constant rate. The best criterion of response to
treatment was considered to be the time taken for an epithelioma to reach aP. N. COWEN
given size, in this case 1 cm. in diameter. This was found to be quite practical,
since all the tumours were nearly circular in plan and had a fairly discrete edge.
When the tumour reached this size the mouse was sacrificed and a post-mortem
examination made.
In the early part of the experiment a high mortality was noted in mice of
Groups 1 and 3. In most cases post-mortem changes in the mice had proceeded
to an extent which made diagnosis of cause of death impossible. Occasionally
ectromelia and mouse typhoid was noted and the deaths were attributed to general
infections. Fig. 1 shows the progress ofthe experiment. The increased mortality
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FIGE. 1.-Mortlit n uordvlpetrtso iepitdwt:2:5:6-Dibenzanthracene.[-
urethane, and both. The plain squares represent mice which died ofinfection, and the shaded
squares represent those mice which were killed while bearing a 1 cm. diameter epithelioma.
in each of Groups 1 and 2 was alive and bearing non-malignant papillomas, and
three mice in Group 3 were alive.
As can readily be seen from Fig. 1, the incidence and time of onset of
epitheliomas was the same in mice of Groups 1 and 2.
Whenthe first mousewithepithelioma in Group 1 was sacrificed and examined
it was found to contain multiple lung tumours. This mouse had been treated
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for 5-6 months. MacroscopicaRy and microseopicaRv the lung tumours were
identical in appearance with those induced by the injection ofurethane (Nettle-
ship and Henshaw, 1943). It was found that aR mice in Groups I and 3 after
six or more mont-hs' treatment, had developed multiple pubnonary adenoni"
which appeared to be typicaBy urethane-induced. No mice.in Group 2 showed
even asinglenmcroswpiclung tumour. Apart from skinand lung tumours, none
ofthe mice sacrificed with epithehomas showed any other obvious pathological
condition.
DUSMSSION.
The results show that, under the experimental conditions described here,
urethane causes no obviouis change in the fi-equency or time of appearance of
papillomas orepithehomas induced by 1:2:5:6--dibenzanthracene. It is of course
possible that urethane might have influenced the development of sMn tumours
under different conditions. Tannenbaum and Silverstone (1947) have pointed
out that massive doses ofcarcinogens tend to masktherapy effects. Consequently
a better test to detect a weakinhibitingactivity ofurethanemight have consisted
of treating mouse sldn with one apphcation of the hydrocarbon, and thereafter
more fi-equent urethane apphcations.
Furthermoretheinformationgainedisapphcable totheendresult. It remains
possible that the details of the proces-ses were not identical. No studies were
made of the histological effects ofurethane on either normal skin or skin under-
going m-ohgnant transformation, since the experiments suggest that any such
effects have httle action on the production of cancer.
It is most interesting to note that those mice which received urethane treat-
ment (Groups I and 3) had multiple lung tumours, whereas those receiving 1:2:
5:6-dibenzanthracene alone (Group 2) had none. The possibihty that the mice
licked the urethane from each other's skin was considered to be most elv.
When urethane was a(iministered to mice in their rinking water in previous
experiments, a reduced fluid consumption was noted for the first few days,
showingtheiraversiontoit. It seemed therefore that the urethane, after apph-
cation to the sldn, was absorbed by the mice m sufficient quantities to induce
lung adenomas. An estimate was made of amount ofurethane in a paint-brush-
fudl of the solution (as painted on the mice) by applying it to a cover shp
and weighing after the acetone had evaporated. Approxi lately 2 mg. was
found to be thus deposited. Am-imin-a all the urethane to be absorbed by the
mouse, this treatment is equivalent to the injection of 0-2 c.c. of a I per cent
urethane solution into the mice each week. For previous studies (Cowen, 1947),
lung tumours in comparable numbers to those obtained here were induced in
various inbred fines ofmice byinjecting 0-25 c.c. of a 10 per cent solutionweekly
for 31 months, and then the mice after a further 4 months. Since total
dosage was not the same, and since there are marked strain differences with
respect tolung tumour responseby different hnes ofmice, no accuratecomparison
can be made. It would be safe to say, however, that alarge part ofthe urethane
apphed to the sldn was absorbed bv the mice in this experiment, judgingby their
tumour re-sponse.
A further indication that the urethane was absorbed isgivenby themortahty
ofthe mice inGroups I and 3, but not in Group 2. It haspreviously been shown
that mice suffer an increased mortahkv when given urethane either by injection
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(Cowen, 1947) or in the drinking water (Cowen, 1950). The death rate
noted here is considered t-o be related to the treatment with urethane.
It is not unreasonable to suppose that urethane is absorbed at least as readily
from nan as from mouse skin. Since urethane causes leueopenia in man
(Moescbliin and Meih, 1947) and lung cancer in mice (Nettleship and Hensbaw,
1943) and rats (Ja56, 1947). it would be well for those who handle this substance
fi-equently in the laboratory or commerciaRv to consider it a possible risk- to
health and consequentlv take effective precautions.
SUM&ARY.
Three groups of mice were painted interscapularly with an acetone solution
of 1:2:5:6-dibenzanthracene, urethane and a mi iture of both each week.
The groups receiving the hydrocarbon or the mixture developed the same
incidence ofepithehomas and at the same rate.
T'he groups receiving urethane or the mixture developed multiple pulmonary
adenomas and showed a mortahty rate.
This points out that most of the urethane apphed to the skin was absorbed
bv it.
AR expenses 'm connection with this work- were borne bv the British Empire
Cancer Campaign..
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